Trevi Therapeutics, Inc.

NASDAQ:TRVI

4 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -29.065-29.152-33.94-32.758-26.05-20.545-12.86-11.087
Depreciation & Amortization 0.1230.0430.050.0470.0390.0230.0040.004
Deferred Income Tax 00-0.0820.009001.3520
Stock Based Compensation 2.2472.3272.5432.4171.1270.4960.2050
Change In Working Capital -3.847-1.2311.5091.0581.576-0.5680.722-1.485
Accounts Receivables 0000.293-0.374-0.135-00.049
Inventory 000-0.2930.374000
Accounts Payables -1.0490.0090.8310.4170.7770.0660.092-1.113
Other Working Capital -2.798-1.240.6780.6410.799-0.6340.63-0.421
Other Non Cash Items -1.168-0.1620.9740.2270.2152.3032.6022.448
Operating Cash Flow -31.71-28.175-28.946-29-23.093-18.291-7.975-11.192
Investing Activities:
Investments In Property Plant And Equipment -0.137-0.1590-0.032-0.009-0.158-0.0130
Acquisitions Net 0-0.829000000
Purchases Of Investments -9.932-126.215000000
Sales Maturities Of Investments 69.49719.001000000
Other Investing Activites 00.8290-0.032-0.009000
Investing Cash Flow 59.428-107.3730-0.032-0.009-0.158-0.0130
Financing Activities:
Debt Repayment -9.504-5.8330140-4.813-8.258.597
Common Stock Issued 1.71105.4121.1833.13565.1-1.52100
Common Stock Repurchased 00000-1.53400
Dividends Paid 0000-2.239000
Other Financing Activities -0.11611.73-0.408-0.41510.3529.97629.9720
Financing Cash Flow -7.91111.30720.77516.720.0730.00421.7228.597
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 19.808-24.241-8.171-12.31250.111-14.81813.734-2.595
Cash At End Of Period 32.39712.58936.8345.00157.3137.20222.028.286